A top official in the intelligence community has disputed the factual basis for the Trump administration’s suppression of a whistleblower complaint believed to regard the potential misconduct of the president himself, a new letter released Thursday revealed.
The letter was made public by House Intelligence Committee Chair Adam Schiff (D-CA). He is locked into a fierce and potentially explosive dispute with an array of forces within the administration to obtain the complaint, which was made through proper channels by an intelligence official last month to the community’s inspector general. Intelligence Community Inspector General Michael Atkinson determined that the complaint was “credible” and “urgent,” and subsequent reporting from the Washington Post found that it concerns a “promise” made by Trump in communication with a foreign leader.
But acting Director of National Intelligence Joseph Maguire, who is supposed to take such urgent complaints from the IG to Congress, has refused to turn over the documents after consulting with the Justice Department about the matter. DNI General Counsel, in consultation with the DOJ, told Schiff and the committee that the law doesn’t require “disclosure of the complaint to the intelligence committees” because it did not concern “allegations of conduct by a member of the intelligence community or involve intelligence activity under the DNI’s supervision.”
In other words, Maguire is trying to claim that he doesn’t need to hand over the whistleblower complaint because it’s out of his jurisdiction. He has also claimed that there are “privilege” concerns involved, which could be plausible given the reported content of the complaint and which may indeed prevent him from disclosing the matter if it’s outside his jurisdiction.
However, it’s precisely this key claim of jurisdiction that Inspector General Atkinson disputes. In the letter to Schiff released Thursday, which has been sent Tuesday, Atkinson flatly stated that the DOJ is wrong.
The “disclosure not only falls within the DNI’s jurisdiction, but relates to one of the most significant and important of the DNI’s responsibility’s to the American people,” he wrote. Because of the disagreement, Atkinson said he has asked to disclose the “general subject matter” of the complaint to Congress, but he has been denied this permission.
He went on to say that his “unresolved differences with the Acting DNI are affecting the execution of two of my most important duties and responsibilities as the Inspector General of the Intelligence Community.” These two duties are his responsibility toward the whistleblower and his duties to the congressional oversight committees.
Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report
According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.
The report, by the Times' Reid Epstein, begins with one such possible scenario.
‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint
Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.
Checking blood for coronavirus antibodies – 3 questions answered about serological tests and immunity
Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This technique is called serological testing.
Virologist Daniel Stadlbauer helped develop a serological test to detect SARS-CoV-2 antibodies and helped transfer it from the research lab to the clinical setting. Epidemiologist Aubree Gordon regularly uses serological assays in her research studies on influenza and dengue fever. She’s now established serological testing for SARS-CoV-2 in her research lab.